Mikamycin軟膏の諸種化膿性皮膚疾患に対する治験

DOI Web Site

書誌事項

タイトル別名
  • Effects of Mikamycin Ointment upon Cases of Pyogenic Dermatoses

抄録

Mikamycin. a new antibiotic developed from Streptomyces mitakaencis isolated from a soil of Mitaka City, Japan, was introduced by Umezawa and others in 1956. It's spectrum covers Gram positive organisms. It has its sister substances such as streptogramin (Charney,1953), Staphylomycin (No.899 substance) (De Somer,1955), PA 114 (Celmer,1955) and E 129(Lees,1958). It has two components, A and B, which act synergetically.<BR>The Kaneka brand Mikamycin contains 70 per cent of A and 7-14 percent of B. One percent and 0.5 per cent Mikamycin vaselin was favorably used in treating 67 cases of impetigo staphylogenes, infectious eczematoid dermatitis, miliaria pustulosa et profunda, furunculosis, acne vulgaris and secondery infection of other dermatoses including strophulus infantum, molluscum contagiosum, tinea pedis, burns, herpes zoster and ulcerated lesion of stasis dermatitis. Especially superficial infections as impetigo staphylogenes showed a dramatic response.

収録刊行物

詳細情報 詳細情報について

問題の指摘

ページトップへ